Last 32.65 INR
Change Today +0.05 / 0.15%
Volume 4.7K
As of 5:00 AM 12/26/14 All times are local (Market data is delayed by at least 15 minutes).

krebs biochemicals & industr (KBC) Snapshot

Open
32.25
Previous Close
32.60
Day High
33.25
Day Low
32.20
52 Week High
09/23/14 - 50.50
52 Week Low
12/31/13 - 11.50
Market Cap
310.6M
Average Volume 10 Days
5.2K
EPS TTM
-24.62
Shares Outstanding
9.5M
EX-Date
09/14/05
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for KREBS BIOCHEMICALS & INDUSTR (KBC)

Related News

No related news articles were found.

krebs biochemicals & industr (KBC) Related Businessweek News

No Related Businessweek News Found

krebs biochemicals & industr (KBC) Details

Krebs Biochemicals & Industries Limited, a biochemical company, manufactures and sells active pharmaceutical ingredients and intermediates in India. It develops biotech processes for application in medicine, agriculture, and industry. The company provides various products for application as anti cholesterols and anti asthmatics. It is also developing an intermediate for Tenofovir Anti HIV; and various products for anti cholesterol, cough and cold, and anti obesity therapeutic areas. Krebs Biochemicals & Industries Limited was founded in 1991 and is headquartered in Hyderabad, India.

Founded in 1991

krebs biochemicals & industr (KBC) Top Compensated Officers

Chairman of The Board, Managing Director, Mem...
Total Annual Compensation: 1.5M
Chief Operating Officer, Compliance Officer a...
Total Annual Compensation: 1.4M
Compensation as of Fiscal Year 2014.

krebs biochemicals & industr (KBC) Key Developments

Krebs Biochemicals & Industries Ltd Approves the Amendments to its Memorandum of Association and Articles of Association

Krebs Biochemicals & Industries Ltd. at its board meeting held on December 13, 2014, approved the amend the memorandum of association and articles of association of the company.

Krebs Biochemicals & Industries Ltd, Board Meeting, Dec 13, 2014

Krebs Biochemicals & Industries Ltd, Board Meeting, Dec 13, 2014. Agenda: To approve the resignation of Sri. R.Ch. Satyanarayana as Director with effect from December 3, 2014 who resigned due to his personal reasons; to increase the authorised share capital of the company from INR 100.00 million to INR 160.00 million; and to amend the memorandum of association and articles of association of the company accordingly.

Krebs Biochemicals & Industries Ltd. Announces Resignation of Satyanarayana as Director

Krebs Biochemicals & Industries Ltd. announced that the Board of Directors of the company at its meeting held on December 13, 2014 has approved the resignation of Sri. R. Ch. Satyanarayana as Director with effect from December 3, 2014 who resigned due to his personal reasons.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
KBC:IN 33.00 INR +0.40

KBC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for KBC.
View Industry Companies
 

Industry Analysis

KBC

Industry Average

Valuation KBC Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 27.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KREBS BIOCHEMICALS & INDUSTR, please visit www.krebsbiochem.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.